These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8535343)

  • 21. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis.
    Perlmutter JS; Kilbourn MR; Welch MJ; Raichle ME
    J Neurosci; 1989 Jul; 9(7):2344-52. PubMed ID: 2787394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
    Mukherjee J; Yang ZY; Brown T; Roemer J; Cooper M
    Life Sci; 1996; 59(8):669-78. PubMed ID: 8761017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography.
    Moerlein SM; Laufer P; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Eur J Nucl Med; 1986; 12(4):211-6. PubMed ID: 2876896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
    Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
    Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE
    Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New fluorine-substituted analogue of eticlopride with high affinity toward dopamine D2 receptors.
    Watanabe K; Fukumura T; Sasaki S; Maeda M; Takehara S
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3211-4. PubMed ID: 1839971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron-emitting N-[18F]fluoroalkyl and [18F]fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D2 receptors.
    Maeda M; Sasaki S; Fukumura T; Fukuzawa E; Watanabe K; Kojima M; Tahara T; Masuda K; Ichiya Y
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1793-8. PubMed ID: 1394695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
    Ingvar M; Stone-Elander S; Rogers GA; Johansson B; Eriksson L; Parsons SM; Widén L
    Neuroreport; 1993 Sep; 4(12):1311-4. PubMed ID: 8260611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of dopamine D
    Liu H; Luo Z; Gu J; Su Y; Flores H; Parsons SM; Zhou Y; Perlmutter JS; Tu Z
    Eur J Pharm Sci; 2020 Feb; 143():105152. PubMed ID: 31740395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.
    Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain.
    Dewey SL; Brodie JD; Fowler JS; MacGregor RR; Schlyer DJ; King PT; Alexoff DL; Volkow ND; Shiue CY; Wolf AP
    Synapse; 1990; 6(4):321-7. PubMed ID: 1981112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.